Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
in all areas · Personalized learning programme to foster our staff’s soft and technical skills · Multicultural and international work environment with more than 50 nationalities
-
and clinical translation. Supported by the Carl Zeiss Foundation , an ERC Starting Grant , and the DFG Emmy Noether Program, our lab provides a highly collaborative and interdisciplinary environment
-
research in Nanoscience and Nanotechnology. The center gives access to a broad range of infrastructure, tools and expertise including clean-room facilities. With a 5 year undergraduate nanotechnology program
-
Job Description The Department of Psychiatry at the University of Tennessee Health Science Center is seeking a full-time Postdoctoral Scholar to join the Department of Psychiatry. This position is of one-year duration but is potentially renewable for an additional one to two years, depending on...
-
The Skinnider Lab at Princeton University aims to recruit a postdoctoral fellow or more senior researcher to work on projects related to computational analysis of chemical and biochemical datasets
-
program that includes lectures, advanced scientific workshops, complementary skill courses and opportunities for career development a mentoring program to guide and promote young scientists Salary: Payment
-
. Description We are looking for a postdoctoral computational biologist to decipher the genomic regulatory code controlling gene expression in plants. Within the ERC-funded multiCODE project, we aim to unravel
-
-funded financial support for salary or stipends (e.g., National Research Foundation Mid-Career Researcher Program, Jang Young-Shil Fellow, or similar programs), duplicate funding is not allowed. Applicants
-
+ imaging, data analysis and neuronal circuits. Requirement PhD in neuroscience, computer science or a related field High motivation for explorative research Experience in neurophysiology (electrophysiology
-
, computational drug repurposing, and de novo design of novel protein-based therapeutics. Our work also includes developing gene editing strategies to correct or inactivate mutations associated with severe